Drug Topics

JULY 17, 2023

Methamphetamine deaths among American Indian and Native Alaskan men and women significantly increased between 1992 and 2019.

187

187

Pharmacy Times

JULY 17, 2023

Effective implementation of the Inflation Reduction Act may allow legislators to shift their focus toward controversial pharmacy benefit manager practices, according to a panel discussion during the ATOPP Summit.

123

123

Drug Topics

JULY 17, 2023

A Q&A with Colin Banas, MD, chief medical officer at health care software company DrFirst.

187

187

Pharmacy Times

JULY 17, 2023

Every pharmacist can make a difference in patients’ lives by taking the time to understand and fulfill the community’s social and cultural needs.

Immunization 123

Immunization 123

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Drug Topics

JULY 17, 2023

Fewer hospitalized patients with COVID-19 pneumonia died when treated with standard care plus either infliximab or abatacept.

Hospitals 98

Hospitals 98

Pharmacy Times

JULY 17, 2023

With approximately 2 years of additional follow-up, lenvatinib plus pembrolizumab maintained robust effectiveness for nearly every patient.

122

122

Pharmacy Times

JULY 17, 2023

The approval marks the first monoclonal antibody approved to protect all infants through their first respiratory syncytial virus season.

FDA 123

FDA 123

STAT

JULY 17, 2023

Doctors have long suspected that hearing loss in older adults hastens dementia, the cognitive decline associated with aging. A new study published in The Lancet on Tuesday probes the link between the two conditions further in what could be the first randomized controlled trial of its kind.  More than 55 million people have dementia worldwide; a number that continues to grow as more people live longer.

FDA 98

FDA 98

Pharmacy Times

JULY 17, 2023

Tooth loss and gum disease may play a role in the health of the brain area that controls thinking and memory.

123

123

STAT

JULY 17, 2023

The Food and Drug Administration approved a monoclonal antibody to protect infants and young children from severe illness caused by RSV on Monday, a potential game-changer for a disease that is the No. 1 cause of hospitalization of babies in this country. Use of the antibody treatment, the brand name for which is Beyfortus, still needs to be recommended by the Advisory Committee on Immunization Practices, an independent expert panel that advises the Centers for Disease Control and Prevention.

Insurance 98

Insurance Immunization FDA Hospitals 98

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Fierce Pharma

JULY 17, 2023

Sanofi’s immunization scheme is starting to fall into place thanks to an approval that could propel it and its partner AstraZeneca to the front lines of the respiratory syncytial virus (RSV) scene. | Sanofi’s immunization scheme is starting to fall into place thanks to an approval that could propel it and its partner AstraZeneca to the front lines of the RSV scene.

Immunization 98

Immunization 98

STAT

JULY 17, 2023

Florida legislators recently passed legislation to prevent advanced practice nurses in Florida with doctorates from using the honorific “doctor.” The state House and Senate bills proposed that nurses with doctorates who introduce themselves to patients as “Dr. Smith, nurse practitioner,” could face disciplinary action. Lobbyists who supported this measure referred to it as a “patient empowerment bill that allows them to understand who is treating them.

98

98

Fierce Pharma

JULY 17, 2023

From its initial nod in generalized myasthenia gravis (gMG) in 2021 to a subcutaneous approval this summer—and now, a stellar showing in a second neuromuscular disease—Argenx’s flagship drug Vyvgar | From its initial nod in generalized myasthenia gravis (gMG) in 2021 to a subcutaneous approval this summer—and now, a stellar showing in a second neuromuscular disease—Argenx’s flagship drug Vyvgart is proving its merit as a potential pipeline product.

98

98

STAT

JULY 17, 2023

Two dominant Blue Cross Blue Shield companies in California intentionally underreported premiums of certain health plans so they could avoid paying Affordable Care Act taxes, according to new federal whistleblower complaints. These claims renew concerns about whether health insurance companies have skirted the tax code and to what extent tax fraud could exist in the industry.

Health Insurance Companies 98

Health Insurance Companies Insurance 98

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Fierce Pharma

JULY 17, 2023

Apellis Pharmaceuticals' Syfovre, after achieving the first FDA approval for advanced eye disease geographic atrophy, has been associated with rare but severe side effects, according to the America | The American Society of Retinal Specialists sent out a note to doctors on Saturday warning of eye inflammation cases in patients who took Syfovre, including six reports of occlusive retinal vasculitis.

FDA 98

FDA 98

Fierce Healthcare

JULY 17, 2023

Friday, the Federal Trade Commission (FTC) announced its withdrawal of two policy statements outlining its former position on antitrust enforcement in healthcare markets, echoing a similar decision | The two policy statements, issued in 1996 and 2011, "no longer reflect market realities in this important sector of the economy," the regulator said.

98

98

The Checkup by Singlecare

JULY 17, 2023

One in 3 adults in the U.S. has prediabetes , and 80% aren’t even aware of it. This means your blood glucose (sugar) levels are higher than normal but not yet at diabetes levels. Prediabetes increases your risk for more severe and life-threatening diseases, such as heart disease, stroke, and Type 2 diabetes. In fact, without intervention, many people with prediabetes will likely have diabetes within five years.

98

98

Fierce Healthcare

JULY 17, 2023

It took less than a week for hospital chain HCA Healthcare to go from a multimillion-patient data breach to a slew of class-action lawsuits alleging negligence and seeking relief. | The for-profit giant “knew or should have known” that the private information it collects is “highly sought after by criminal parties,” plaintiffs wrote in one complaint.

Hospitals 98

Hospitals 98

STAT

JULY 17, 2023

This is part of a series about new obesity drugs that are transforming patients’ lives, dividing medical experts, and spurring one of the biggest business battles in years. Read more about  The Obesity Revolution. LOS ANGELES — On this pleasant spring day, patients and uniformed health care workers crisscross the UCLA medical campus like ants on a picnic table.

98

98

The Checkup by Singlecare

JULY 17, 2023

Compare oxycodone alternatives | NSAIDs | Tylenol | Muscle relaxants | Other opioids | Neurological medications | Natural alternatives | How to switch meds Pain in any form is a condition that can affect many aspects of a person’s quality of life. This can include their mental health, physical functioning, and financial aspects of their life as well.

Controlled Substances 98

Controlled Substances Insurance Coverage Insurance Labelling 98

Fierce Healthcare

JULY 17, 2023

Alzheimer's disease drug Leqembi recently secured full approval from the Food and Drug Administration (FDA), and more expansive coverage from Medicare followed. | If projections are met, the new Alzheimer's drug meant to slow cognitive decline will cost Medicare more than $2 billion. Does Leqembi show enough promise to override its high costs and safety concerns?

FDA 98

FDA 98

Fierce Pharma

JULY 17, 2023

With the acquisition of two commercial medicines from Travere Therapeutics, liver disease specialist Mirum Pharmaceuticals has gone from a company with one product to having a “franchise,” accordin | With the acquisition of two commercial medicines from Travere Therapeutics, liver disease specialist Mirum Pharmaceuticals has gone from a company with one product to having a “franchise,” according to CEO Chris Peetz.

98

98

Hospital Pharmacy Europe

JULY 17, 2023

Immune checkpoint inhibitors have transformed the management of non-small cell lung cancer, but how long should treatment be continued for optimal survival? Rod Tucker takes a closer look at the evidence. It has long been recognised that a hallmark of cancer is immune evasion and that the immune system is held back by inhibitory immune checkpoint receptors and ligands.

Immunization 98

Immunization Hospitals FDA 98

Pharma Marketing Network

JULY 17, 2023

Amy Turnquist has more than 20 years of experience leading teams to create and deliver innovative, client-centric solutions that connect pharmaceutical brands with their HCP and consumer audiences. In her role as a Principal at North Highland, Amy helps healthcare organizations transform their engagement strategy, driving sustainable change and measurable impact by keeping people at the heart of every decision.

98

98

STAT

JULY 17, 2023

QuidelOrtho has recalled nearly 8,000 potentially faulty blood tests meant to help doctors quickly determine whether a patient is having a heart attack. The tests inaccurately showed low levels of troponin, a protein that indicates damage to the heart. A false negative could lead doctors to mistakenly conclude their patient is not having a heart attack, delaying diagnosis or treatment when time is of the essence.

Hospitals 98

Hospitals FDA 98

Pharmacy Times

JULY 17, 2023

FDA approvals of these biosimilars started in 2016, but only 1 such product has successfully launched.

FDA 123

FDA 123

STAT

JULY 17, 2023

Westlake Village BioPartners, a West Coast biotech venture capital firm founded five years ago by two Amgen veterans, has raised a new fund and brought in two veteran investors from another biotech VC as one of its founders takes a back seat. Westlake just raised $450 million for its third fund. It’s the first without the involvement of co-founder Sean Harper, who started the firm in 2018 with his Amgen colleague Beth Seidenberg.

98

98

Fierce Pharma

JULY 17, 2023

Despite a second wind for Actemra courtesy of the COVID-19 pandemic, Roche has warned the interleukin-6 inhibitor’s blockbuster sales run is nearing its end. | Roche and its subsidiaries Genentech and Chugai Pharmaceutical late last week mounted a lawsuit in Massachusetts over claims that Biogen’s proposed biosimilar to Actemra, BIIB800, violates multiple plaintiff-held patents.

97

97

STAT

JULY 17, 2023

Big businesses poised to profit from the advance of artificial intelligence in health care are pushing back against newly proposed federal rules meant to increase oversight and fairness of AI tools used to help make decisions about patient care. The opposition, which includes Google and Amazon as well as large health care providers, insurers, and medical software vendors, is focused on an attempt to put tighter guardrails around the use of AI by the Office of the National Coordinator for Health

Insurance 98

Insurance Patient Care 98

PharmExec

JULY 17, 2023

In this Q&A, Craig Serra, head of commercial solutions and partnerships within the clinical research business unit at Flatiron Health (affiliate of the Roche Group), shares his perspective on clinical research, the role of data, and Flatiron Health’s efforts to that end.

97

97

STAT

JULY 17, 2023

At the turn of the century, nearly 18 million women in the United States were battling hot flashes, night sweats, and other symptoms of menopause with hormones. But in 2002, the therapy went into a free-fall when a landmark trial suggested treating menopause with estrogen and progesterone increased the risk of breast cancer and cardiovascular disease.

98

98

Drug Store News

JULY 17, 2023

The ‘My Skin & Hair Journey’ study looks to help researchers better understand the biological, clinical and environmental factors that contribute to skin and hair health.

97

97

STAT

JULY 17, 2023

The health records company NextGen Healthcare will pay $31 million to resolve allegations that it paid kickbacks to win customers and concealed shortcomings of its software to gain government certification. The settlement caps a lengthy investigation that cast a harsh light on NextGen’s efforts to gain market share in the sharp-elbowed business of selling electronic health records software.

Hospitals 97

Hospitals 97

European Pharmaceutical Review

JULY 17, 2023

A new three-year research programme led by researchers at Massachusetts Institute of Technology ( MIT ) is aiming to design the world’s first fully integrated, continuous mRNA manufacturing platform. The resulting pilot-scale system is intended to improve society’s ability to respond to future pandemics as well as accelerate the development and production of mRNA technologies.

FDA 96

FDA Vaccines 96